Particulars (Rs. In cr) | Q1FY25 | Q1FY24 | YoY (%) | Q4FY24 | QoQ (%) |
---|---|---|---|---|---|
Revenue from Operations | 906.00 | 826.00 | 10.00% | 891.00 | 2.00% |
EBITDA | 216.50 | 190.00 | 14.00% | 211.00 | 3.00% |
EBITDA Margin (%) | 23.90% | 23.00% | 90 bps | 23.68% | 22 bps |
PAT | 150.00 | 137.00 | 10.00% | 147.00 | 2.00% |
EPS (Rs.) | 3.50 | 3.13 | 12.00% | 3.41 | 3.00% |
Source: Company Filings; stockaxis Research
Q1FY25 Result Highlights
Emami reported Q1FY25 earnings better than expectations driven by strong volume
growth. Consolidated net sales grew 10% YoY to Rs.906 cr. The domestic business
grew 10% YoY, led by 9% volume growth. There was a sequential improvement in demand
in the rural market. International business grew 10%and 11% growth in CC terms,
driven by double-digit growth in MENA and SAARC regions. The overall oral care category
is grown by 10% in 1QFY25.
Harsh summer translated into strong demand for cooling products. Growth was led by Navratna and Dermicool (27%) due to strong summers and was supplemented by 11% growth in Healthcare, 9% growth in 7 Oils in One & 4% in Boroplus. Kesh King (15% de-growth), Pain Management (7% de-growth) & Malegrooming (5% de-growth) continue to remain under pressure Conversely, the severe summer hurt the pain management range (-7% YoY). Kesh King and male grooming dipped 15% and 5% YoY, respectively.
Gross Margins expanded 228 bps to 67.7%. Due to reinvestment in the business and higher ad spends which rose 21% YoY (up 188bps), EBITDA margin saw limited 90bps YoY expansion to 23.9% (in line). MT grew 25% YoY, and e-commerce rose 29% YoY. Both contributed 22% of revenue. PAT grew by 10% YoY to Rs.150 cr which managed to beat estimates.
Performance and outlook
Cost and Margins
Segmental outlook
Emami delivered better than expected earnings for the quarter ended Q1FY25 on the back of higher volume growth. Management remains optimistic about the company’s growth prospects supported by a favourable economic landscape, forecast of a normal monsoon, anticipated rural market recovery, government initiatives, and promising macroeconomic factors, all contributing to a promising outlook for sustained positive performance. We anticipate that the double-digit growth will be aided by the strong summer season, favourable base for the winter season, and rural recovery driven by a normal monsoon, distribution expansion efforts, robust performance in key products. We continue to expect volume growth acceleration in FY25, driven by rural pickup, seasonal tailwinds, aggressive marketing spends, and new launches. At CMP of Rs.812, the stock is trading at 35x FY26E. We maintain HOLD rating on the stock.
Particulars (Rs. In cr) | Q1FY25 | Q1FY24 | YoY (%) | Q4FY24 | QoQ (%) |
---|---|---|---|---|---|
Revenue from Operations | 906.00 | 826.00 | 10.00% | 891.00 | 2.00% |
COGS | 293.00 | 286.00 | 2.00% | 305.00 | -4.00% |
Gross Profit | 613.00 | 540.00 | 14.00% | 586.00 | 5.00% |
Gross Margin (%) | 67.66% | 65.38% | 228 bps | 66.00% | 166 bps |
Employee Benefit expenses | 111.00 | 101.00 | 10.00% | 90.00 | 23.00% |
Other expenses | 285.50 | 249.00 | 15.00% | 285.00 | 0.00% |
EBITDA | 216.50 | 190.00 | 14.00% | 211.00 | 3.00% |
EBITDA Margin (%) | 23.90% | 23.00% | 90 bps | 23.68% | 22 bps |
Depreciation and amortisation expenses | 44.00 | 46.00 | -4.00% | 48.00 | -8.00% |
EBIT | 172.50 | 144.00 | 20.00% | 163.00 | 6.00% |
Finance cost | 2.00 | 2.00 | 0.00% | 3.00 | -33.00% |
Other Income | 10.00 | 8.00 | 25.00% | 11.00 | -9.00% |
Profit before Share of loss of associates, and Tax | 180.50 | 150.00 | 20.00% | 171.00 | 6.00% |
Share of Loss of associates | -2.00 | -0.50 | -1.57 | ||
Profit before Tax and Exceptional Item | 178.00 | 150.00 | 19.00% | 169.43 | 5.00% |
Exceptional item | - | - | - | ||
Profit before Tax | 178.00 | 150.00 | 19.00% | 169.43 | 5.00% |
Tax expenses | 28.00 | 13.00 | 115.00% | 22.48 | 25.00% |
PAT | 150.00 | 137.00 | 10.00% | 147.00 | 2.00% |
EPS (Rs.) | 3.50 | 3.13 | 12.00% | 3.41 | 3.00% |